Literature DB >> 20360261

MicroRNAs and heart failure diagnosis: MiR-acle or MiR-age?

David W Markham, Joseph A Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20360261      PMCID： PMC3612275          DOI： 10.1161/CIRCRESAHA.110.219030

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  22 in total

Review 1.  MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.

Authors:  Eva van Rooij; Eric N Olson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

2.  Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.

Authors:  Angela B Y Hui; Michelle Lenarduzzi; Tiffaney Krushel; Levi Waldron; Melania Pintilie; Wei Shi; Bayardo Perez-Ordonez; Igor Jurisica; Brian O'Sullivan; John Waldron; Pat Gullane; Bernard Cummings; Fei-Fei Liu
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

3.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.

Authors:  Guo-Kun Wang; Jia-Qi Zhu; Jun-Tao Zhang; Qing Li; Yue Li; Jia He; Yong-Wen Qin; Qing Jing
Journal:  Eur Heart J       Date:  2010-02-16       Impact factor: 29.983

4.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

7.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.

Authors:  Shusheng Wang; Arin B Aurora; Brett A Johnson; Xiaoxia Qi; John McAnally; Joseph A Hill; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

8.  Plasma miR-208 as a biomarker of myocardial injury.

Authors:  Xu Ji; Rie Takahashi; Yumiko Hiura; Go Hirokawa; Yasue Fukushima; Naoharu Iwai
Journal:  Clin Chem       Date:  2009-08-20       Impact factor: 8.327

9.  CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Authors:  Mohamed Guled; Leo Lahti; Pamela M Lindholm; Kaisa Salmenkivi; Izhar Bagwan; Andrew G Nicholson; Sakari Knuutila
Journal:  Genes Chromosomes Cancer       Date:  2009-07       Impact factor: 5.006

Review 10.  MicroRNAs: regulating a change of heart.

Authors:  Kurt G Barringhaus; Phillip D Zamore
Journal:  Circulation       Date:  2009-04-28       Impact factor: 29.690
View more
  7 in total

1.  Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Ahamed A Khalyfa; David Gozal
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

2.  The importance of being ncRNAs: from bit players as "junk DNA" to rising stars on the stage of the pharmaceutical industry.

Authors:  Vittoria Di Mauro; Daniele Catalucci
Journal:  Ann Transl Med       Date:  2017-03

3.  Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.

Authors:  Kun Wang; Zhi-Qiang Lin; Bo Long; Jian-Hui Li; Jing Zhou; Pei-Feng Li
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

4.  Circulating MicroRNAs as Potential Biomarkers for Ischemic Stroke in Patients with Asymptomatic Intracranial Artery Stenosis.

Authors:  Jia Zhang; Yuan Shen; Kaijiang Kang; Jinxi Lin; Anxin Wang; Shangzhi Li; Shouling Wu; Xingquan Zhao; Qian Zhang
Journal:  Cell Mol Neurobiol       Date:  2022-07-28       Impact factor: 4.231

5.  MicroRNA 449a can Attenuate Protective Effect of Urokinase Against Pulmonary Embolism.

Authors:  Ran Zhu; Wei-Yi Qi; Ting-Wei Liu; Fan Liu
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

6.  Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage.

Authors:  Hong-Wei Zheng; Yi-Long Wang; Jin-Xi Lin; Na Li; Xing-Quan Zhao; Gai-Fen Liu; Li-Ping Liu; Yan Jiao; Wei-Kuan Gu; David Z Wang; Yong-Jun Wang
Journal:  CNS Neurosci Ther       Date:  2012-12       Impact factor: 5.243

7.  MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism.

Authors:  Junjie Xiao; Zhi-Cheng Jing; Patrick T Ellinor; Dandan Liang; Hong Zhang; Ying Liu; Xiaoli Chen; Lei Pan; Robert Lyon; Yi Liu; Lu-Ying Peng; Xingqun Liang; Yunfu Sun; Laurentiu M Popescu; Gianluigi Condorelli; Yi-Han Chen
Journal:  J Transl Med       Date:  2011-09-24       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.